DESREM™| Patient Monitoring Recommendations
To know about DESREMTM availability in the market, guide your patients to reach Viatris® COVID-19 24/7 helpline @ 7829980066, Email:


Given the limited experience with remdesivir at the recommended dose and duration, patients should have appropriate clinical and laboratory monitoring to aid in early detection of any potential adverse events while receiving remdesivir. The following laboratory tests should be performed daily while receiving remdesivir: serum chemistries, hematology, ALT, AST, bilirubin, and alkaline phosphatase; renal function tests (creatinine and creatinine clearance).

DESREM™, Remdesivir Prescribing Information. Mylan Laboratories Limited. 2020.